Netcracker Receives Three Gold Stevies in 2025 American Business Awards
Netcracker’s Groundbreaking Satellite, MVNO Cloud and Intelligent Operations Automation Solutions Attain Top Honors in Premier…
1 year ago
Alex
77% of Germans Want Robots in the Workplace – automatica Trend Report 2025
MUNICH--(BUSINESS WIRE)--#AI--The vast majority of employees in Germany believe that robot deployment in factories will…
1 year ago
Soaring in 2025: STARLUX Celebrates Ontario-Taipei Inaugural Flight – Its 4th US Destination and 2nd Gateway in Greater L.A.
Gate launch event heralds expanded travel options from Greater Los Angeles, connecting STARLUX passengers to…
1 year ago
BELFOR Highlights Digital Transformation in Damage Assessment at Asia Claims Convention 2025 in Osaka
OSAKA, Japan--(BUSINESS WIRE)--#AsiaClaimsConvention2025--BELFOR, the world’s leading provider of disaster recovery and property restoration services, recently…
1 year ago
ROI·DNA Expands Global Footprint to Accelerate Growth for International B2B Technology Brands
Integrated team across EMEA, APAC, and North America positions ROI·DNA as the go-to growth partner…
1 year ago
Lenovo and Bellevue University Team Up to Offer Supply Chain and Logistics Education to Deliver “Smarter Technology for Allâ€
Learners will have access to Lenovo’s globally recognized supply chain expertise through real-world case studies…
1 year ago
Arizona Sonoran Appoints Hannam & Partners as Project Finance Advisor for the Cactus Project
CASA GRANDE, Ariz. & TORONTO--(BUSINESS WIRE)--$ASCU #Arizona--Arizona Sonoran Copper Company Inc. (TSX:ASCU | OTCQX:ASCUF) (“ASCU 
1 year ago
KKR Provides $600 Million Financing to Indian Conglomerate Manipal Group
Transaction marks KKR’s latest and largest credit investment in IndiaMUMBAI, India--(BUSINESS WIRE)--KKR, a leading global…
1 year ago
MarkHerz Signs MOU with TUM Hospital for Joint Development of Cardiovascular and Diabetes-Targeted AAV Gene Therapies
Paving the Way for European Clinical Entry and Global Technology Transfer A Milestone Partnership Highlighting…
1 year ago
ImmunAbs Announces FDA Phase 2 IND Approval of IM-101, a Novel Complement C5 Inhibitor, for Treatment of Myasthenia Gravis
SEOUL, South Korea--(BUSINESS WIRE)--ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced…
1 year ago